Marijuana penny stocks are ending the week strong. Most of these stocks are trading high on the CSE and TSXV this morning. Major marijuana stocks are trending upwards as well, so the industry might head into the weekend with strong gains.
Today, we'll take a look at a marijuana company that is making major headlines today. The company has just released monumental news in the medical cannabis space that will forever change the industry. If you're an investor looking for a few marijuana penny stocks to add to your portfolio, you may want to take a closer look at this one!
Aleafia Health Inc. (TSXV:ALEF)
Aleafia Health is a medicinal cannabis company, headquartered in Concord, Ontario. The marijuana stock is up almost 50% in 2019 so far.
Aleafia focuses specifically on medical cannabis consultation services and treating patients with chronic pain and other disabling illnesses. The company operates its medical clinics under the Canabo Medical clinic brand.
This morning, Aleafia announced major news that has caused its share prices to spike. Currently, ALEF is leading the marijuana penny stocks on the TSXV for most trades and most trade volume.
A few hours ago, Aleafia released what is believed to be the first study reporting reduced benzodiazepine use among patients treated with medical cannabis. Benzodiazepines are a class of psychoactive drugs that are widely used as common sedatives and anti-anxiety medications.
>> MRMD Stock Up 11%, is MariMed Hemp the Reason?
“The study results are encouraging, and this work is concurrent with growing public interest in a rapidly developing Canadian cannabis market,” said lead author Chad Purcell. “We are advising the public to observe caution. The results do not suggest that cannabis should be used [as] an alternative to conventional therapies. Our purpose is inspiring others to advance current cannabis understanding as we collect stronger efficacy and safety data that will lead to responsible policy and recommended practices for use.”
This peer-reviewed study held 146 patients that found that 45.2% of patients stopped taking their regular dose of benzodiazepines after being treated with medicinal cannabis for six months.
According to Yahoo Finance, ALEF is still leading the marijuana penny stocks. At the time of writing, the stock is trading at $2.09 a share, up +$0.34 (+19.43%).
Featured Image: Canva
